Cargando…

[(18)F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters

Detalles Bibliográficos
Autores principales:	Polizzotto, Mark N, Millo, Corina, Uldrick, Thomas S, Aleman, Karen, Whatley, Millie, Wyvill, Kathleen M, O’Mahony, Deidre, Marshall, Vickie, Whitby, Denise, Steinberg, Seth M, Little, Richard F, Yarchoan, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330077/ http://dx.doi.org/10.1186/1750-9378-7-S1-P48

Ejemplares similares

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease
por: Polizzotto, Mark N, et al.
Publicado: (2010)

Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
por: Yarchoan, R, et al.
Publicado: (2009)

Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
por: Uldrick, Thomas S, et al.
Publicado: (2012)

Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV–MCD) and the KSHV Inflammatory Cytokine Syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2012)

Corrigendum: Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV–MCD) and the KSHV inflammatory cytokine syndrome
por: Polizzotto, Mark N., et al.
Publicado: (2017)

Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
por: Marshall, Vickie, et al.
Publicado: (2012)

A Phase Ib Study of Sorafenib (BAY 43‐9006) in Patients with Kaposi Sarcoma
por: Uldrick, Thomas S., et al.
Publicado: (2017)

Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions
por: Marshall, Vickie A., et al.
Publicado: (2018)

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
por: Burbelo, Peter D, et al.
Publicado: (2010)

Evaluation of Non-Invasive Multispectral Imaging as a Tool for Measuring the Effect of Systemic Therapy in Kaposi Sarcoma
por: Kainerstorfer, Jana M., et al.
Publicado: (2013)

Heterogeneity and Breadth of Host Antibody Response to KSHV Infection Demonstrated by Systematic Analysis of the KSHV Proteome
por: Labo, Nazzarena, et al.
Publicado: (2014)

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA
por: Gruffaz, Marion, et al.
Publicado: (2020)

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2022)

Intense (18)F-Fluoro-deoxyglucose Uptake in Benign Adrenal Nodule
por: Goel, Taruna, et al.
Publicado: (2017)

Co-Existence of Multicentric Castleman's Disease and Kaposi's Sarcoma
por: Yaghoobi, Reza, et al.
Publicado: (2015)

Intense focal Fluoro-deoxyglucose uptake in the lungs with no corresponding computed tomography abnormality
por: Puranik, Ameya D., et al.
Publicado: (2013)

18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report
por: Liu, Willy, et al.
Publicado: (2017)

Simultaneous lymph node involvement by Castleman disease and Kaposi sarcoma
por: Pinto, Luciana Wernersbach, et al.
Publicado: (2011)

T-cell responses to KSHV infection: a systematic approach
por: Roshan, Romin, et al.
Publicado: (2017)

Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate
por: Kwon, Taekmin, et al.
Publicado: (2015)

Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening
por: Sekiguchi, Masau, et al.
Publicado: (2017)

“Metabolic signature” of the lesions on F18-fluoro-deoxyglucose positron emission tomography: A clue to the underlying pathology
por: Kashyap, Raghava, et al.
Publicado: (2014)

Symmetric increased skeletal muscular uptake of F-18 fluoro-deoxyglucose: A clue for the diagnosis of Graves’ disease
por: Santhosh, Sampath, et al.
Publicado: (2011)

Lynch Syndrome Associated Colon Adenocarcinoma Resembling Lymphoma on Fluoro-Deoxyglucose-Positron Emission Tomography/Computed Tomography
por: Aparici, Carina Mari, et al.
Publicado: (2015)

Primary Retroperitoneal Seminoma Staging and Surveillance by Means of Fluoro-2-Deoxyglucose-Positron Emission Tomography/Computed Tomography
por: Liu, Tianye, et al.
Publicado: (2015)

Clinically determined type of (18)F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer
por: Chong, Jae Uk, et al.
Publicado: (2017)

Intense fluoro-2-deoxyglucose uptake in high-grade prostatic adenocarcinoma with negligible prostate-specific membrane antigen expression
por: Cakir, Tansel, et al.
Publicado: (2019)

Differential diagnosis of relapsing polychondritis from asthma by 18‐fluoro‐2‐deoxyglucose positron emission tomography and computed tomography
por: Ono, Mariko, et al.
Publicado: (2021)

Fluoro-deoxyglucose-positron emission tomography/CT scan in superior vena cava syndrome due to radiation-induced fibrosis
por: Kagohashi, Katsunori, et al.
Publicado: (2021)

Preoperative prediction of the pathological stage of advanced gastric cancer by (18)F-fluoro-2-deoxyglucose positron emission tomography
por: Yamada, Kota, et al.
Publicado: (2022)

Multicentric Castleman’s Disease and Kaposi’s Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy
por: Ortega, Lauro, et al.
Publicado: (2014)

Role of (18)F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively
por: Park, Jeon-Woo, et al.
Publicado: (2011)

Recent Chemotherapy Reduces the Maximum-Standardized Uptake Value of (18)F-Fluoro-Deoxyglucose Positron Emission Tomography in Colorectal Cancer
por: Lee, Minjong, et al.
Publicado: (2014)

Effect of duration of fasting and diet on the myocardial uptake of F-18-2-fluoro-2-deoxyglucose (F-18 FDG) at rest
por: Kumar, Pankaj, et al.
Publicado: (2014)

Fluorine-18 fluoro-2-deoxyglucose positron emission tomography/computed tomography in a case of suspected primary pericardial mesothelioma
por: Senthil, Raja, et al.
Publicado: (2012)

Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study
por: Chen, Zhong-Wei, et al.
Publicado: (2021)

Osteoid osteoma of the rib with strong F-18 fluoro-deoxyglucose uptake mimicking osteoblastoma: a case report with literature review
por: Ishikura, Yuka, et al.
Publicado: (2021)

Kaposi Sarcoma Herpes Virus-associated Hemophagocytic Syndrome Complicated by Multicentric Castleman Disease and Kaposi Sarcoma in a HIV-negative Immunocompetent Patient: An Autopsy Case
por: Kim, Bomi, et al.
Publicado: (2009)

Outcome in Patients with Fever of Unknown Origin whose (18)Fluoro-Deoxyglucose Positron Emission Tomography/Computerized Tomography Finding is Non-Diagnostic
por: Kim, Tark, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k0am1vsftec56m3jk2n4v92cog